ARTICLE | Clinical News
Zomig-ZMT zolmitriptan oral 5HT1D receptor agonist regulatory update
February 20, 2001 8:00 AM UTC
The FDA granted marketing approval for a fast-dissolving formulation of Zomig to treat migraine. The formulation, which also is approved in Europe, uses CIMA's DuraSolv drug delivery technology. ...